Johnson & Johnson Settles Risperdal Claim in Texas

Thursday, January 19, 2012 - 22:50 in Psychology & Sociology

Johnson & Johnson said it would pay $158 million to end a lawsuit that accused it of inappropriately marketing its Risperdal antipsychotic drug to Texas residents on Medicaid.

Read the whole article on NY Times Health

More from NY Times Health

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net